TG Therapeutics, Inc. (FRA:NKB2)
27.40
+1.38 (5.32%)
At close: Dec 4, 2025
TG Therapeutics Market Cap
TG Therapeutics has a market cap or net worth of €3.87 billion as of December 5, 2025. Its market cap has decreased by -3.85% in one year.
Market Cap
3.87B
Enterprise Value
3.97B
Revenue
453.34M
Ranking
n/a
PE Ratio
10.14
Stock Price
€27.40
Market Cap Chart
Since January 10, 2012, TG Therapeutics's market cap has increased from 8.02M to 3.87B, an increase of 48,118.20%. That is a compound annual growth rate of 55.92%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 98.87B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.10B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |